CORCEPT THERAPEUTICS INC Operating Lease, Right-of-Use Asset, Amortization Expense
CORCEPT THERAPEUTICS INC (CORT) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $741.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-02-24
- CORCEPT THERAPEUTICS INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $193.00K, a 7.82% increase year-over-year.
- CORCEPT THERAPEUTICS INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $188.00K, a 3.87% increase year-over-year.
- CORCEPT THERAPEUTICS INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was $183.00K, a 50.00% increase year-over-year.
- CORCEPT THERAPEUTICS INC operating lease, right-of-use asset, amortization expense for the quarter ending 2025-03-31 was $177.00K, a 200.00% increase year-over-year.
- CORCEPT THERAPEUTICS INC operating lease, right-of-use asset, amortization expense for fiscal 2025 was $741.00K, a 36.97% increase from fiscal 2024.
- CORCEPT THERAPEUTICS INC operating lease, right-of-use asset, amortization expense for fiscal 2024 was $541.00K, a 59.02% decline from fiscal 2023.
- CORCEPT THERAPEUTICS INC operating lease, right-of-use asset, amortization expense for fiscal 2023 was $1.32M, a 39.64% decline from fiscal 2022.
- CORCEPT THERAPEUTICS INC operating lease, right-of-use asset, amortization expense for fiscal 2022 was $2.19M, a 9.62% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $381.00K derived: sum of 2 quarters · filed 2026-02-24 | $564.00K derived: sum of 3 quarters · filed 2026-02-24 | $741.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | $188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $371.00K derived: sum of 2 quarters · filed 2025-11-04 | $548.00K 10-Q · filed 2025-11-04 | $727.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2025-06-30 | $183.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $360.00K 10-Q · filed 2025-07-31 | $539.00K derived: sum of 3 quarters · filed 2026-02-24 | $720.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2025-03-31 | $177.00K 10-Q · filed 2025-05-05 | $356.00K derived: sum of 2 quarters · filed 2026-02-24 | $537.00K derived: sum of 3 quarters · filed 2026-02-24 | $659.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $360.00K derived: sum of 2 quarters · filed 2026-02-24 | $482.00K derived: sum of 3 quarters · filed 2026-02-24 | $541.00K 10-K · filed 2026-02-24 |
| 2024-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $303.00K derived: sum of 2 quarters · filed 2025-11-04 | $362.00K 10-Q · filed 2025-11-04 | $420.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $122.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $181.00K 10-Q · filed 2025-07-31 | $239.00K derived: sum of 3 quarters · filed 2026-02-24 | $296.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $59.00K 10-Q · filed 2025-05-05 | $117.00K derived: sum of 2 quarters · filed 2026-02-24 | $174.00K derived: sum of 3 quarters · filed 2026-02-24 | $811.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $115.00K derived: sum of 2 quarters · filed 2026-02-24 | $752.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.32M 10-K · filed 2026-02-24 |
| 2023-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $694.00K derived: sum of 2 quarters · filed 2024-10-30 | $1.26M 10-Q · filed 2024-10-30 | $1.83M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $637.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $1.21M 10-Q · filed 2024-07-29 | $1.77M derived: sum of 3 quarters · filed 2025-02-26 | $2.33M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $568.00K 10-Q · filed 2024-05-01 | $1.13M derived: sum of 2 quarters · filed 2025-02-26 | $1.69M derived: sum of 3 quarters · filed 2025-02-26 | $2.24M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $564.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.12M derived: sum of 2 quarters · filed 2025-02-26 | $1.67M derived: sum of 3 quarters · filed 2025-02-26 | $2.19M 10-K · filed 2025-02-26 |
| 2022-09-30 | $557.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $1.11M derived: sum of 2 quarters · filed 2023-11-01 | $1.62M 10-Q · filed 2023-11-01 | $2.13M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $552.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $1.07M 10-Q · filed 2023-08-02 | $1.57M derived: sum of 3 quarters · filed 2024-02-15 | $2.08M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $514.00K 10-Q · filed 2023-05-03 | $1.02M derived: sum of 2 quarters · filed 2024-02-15 | $1.52M derived: sum of 3 quarters · filed 2024-02-15 | $2.02M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $508.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $1.01M derived: sum of 2 quarters · filed 2024-02-15 | $1.51M derived: sum of 3 quarters · filed 2024-02-15 | $2.00M 10-K · filed 2024-02-15 |
| 2021-09-30 | $502.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $998.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.49M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $496.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $985.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $489.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $1.71M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |